Lecturers’ union welcomes move to simplify reporting of sexual harassment and protect academic freedom. A proposed change to Norway’s university governance law could improve how sexual harassment is reported, how exams are monitored and how academic freedom is protected.
There are millions of people who face the loss of their eyesight from degenerative eye diseases. The genetic disorder retinitis pigmentosa alone affects 1 in 4,000 people worldwide.
Allergan announced it is launching a direct-to-consumer (DTC) broadcast TV advertising campaign for Restasis (cyclosporine ophthalmic emulsion) 0.05%, launching April 2021.
All universities have increased or maintained their share of open-access articles in the past year. Three universities in Denmark have exceeded this year’s target of publishing 63 per cent of scientific articles in an open-access format, according to the sixth edition of the Danish open-access indicator.
If you're one of the many people who've switched to working at home during the COVID-19 pandemic, you need to take care of your eyes, the American Academy of Ophthalmology says.
Ocuphire Pharma announced that it has screened the first patient in ZETA-1, a phase 2 trial to evaluate APX3330 in non-proliferative diabetic retinopathy (NPDR) and mild proliferative diabetic retinopathy (PDR). Effects on diabetic macular edema will be explored as a secondary outcome. A number of retinal centers across the US are active and recruiting eligible diabetic retinopathy patients.
The Biden administration began to flesh out a proposal for a new agency—modeled on the military’s Defense Advanced Research Projects Agency (DARPA)—that would seek to speed the development of medical treatments by funding risky, innovative projects. The agency, dubbed ARPA-Health (ARPA-H), would be housed at the National Institutes of Health and have a 2022 budget of $6.5 billion.
Santen announced a research initiative with scientists from Massachusetts Eye and Ear, and Ulster University, UK, to research and develop novel treatments for glaucoma.
Government comes up with 11th hour funds to help meet association cost after lobbying effort by science leaders. But critics still call plan ‘very opaque’, and say it isn’t enough
Alcon has announced the availability of AcrySof IQ PanOptix UV IOL, AcrySof IQ PanOptix Toric UV IOL, AcrySof IQ Vivity UV IOL, and AcrySof IQ Vivity Toric UV IOL as part of the presbyopia-correcting lens portfolio in Canada.
Small and medium-sized companies can apply for grants of up to €2.5M and direct equity investments of up to €15M in the first calls
US president’s first budget proposal emphasizes applied research and public health, and aims to tackle climate change and racial injustice.
Essilor will unveil pivotal 2-year clinical trial results of its Stellest lens for myopia. The 2-year results demonstrate that Essilor Stellest lenses slow down myopia progression by 67% on average, when compared to single vision lenses, when worn at least 12 hours a day, according to Essilor.
Commissioner Mariya Gabriel will oversee the implementation of the Horizon Europe scheme.
Nicox SA anounces the publication of Preclinical Efficacy Results on a new class of Non-PGA NO-Donating IOP-Lowering Compounds